Mild cognitive impairment in Parkinson's disease is associated with a distributed pattern of brain white matter damage

Human Brain Mapping

Volumn 35, Issue 5, 2014, Pages 1921-1929

  Agosta, Federica ^a   Canu, Elisa ^a   Stefanova, Elka ^b   Sarro, Lidia ^a   Tomić, Aleksandra ^b   Špica, Vladana ^b   Comi, Giancarlo ^a   Kostić, Vladimir S ^b   Filippi, Massimo ^a  

^a VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^b UNIVERSITY OF BELGRADE   (Serbia)

Author keywords

Diffusion tensor MRI; Mild cognitive impairment; MRI; Parkinson's disease; White matter damage

Indexed keywords

ADULT; AGED; ARTICLE; ATTENTION; BRAIN ATROPHY; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; COGNITION; CONTROLLED STUDY; CORPUS CALLOSUM; DEPTH PERCEPTION; DIFFUSION TENSOR IMAGING; DISEASE ASSOCIATION; EDUCATIONAL STATUS; EXECUTIVE FUNCTION; FEMALE; GRAY MATTER ATROPHY; HAMILTON SCALE; HUMAN; LANGUAGE ABILITY; MALE; MEMORY; MILD COGNITIVE IMPAIRMENT; MINI MENTAL STATE EXAMINATION; NEUROIMAGING; NEUROPSYCHOLOGICAL TEST; ORIENTATION; PARKINSON DISEASE; PATIENT ASSESSMENT; PRIORITY JOURNAL; UNIFIED PARKINSON DISEASE RATING SCALE; VOXEL BASED MORPHOMETRY; WHITE MATTER DAMAGE; WHITE MATTER LESION; BRAIN MAPPING; COMPLICATION; IMAGE PROCESSING; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; SEVERITY OF ILLNESS INDEX; VERY ELDERLY; WHITE MATTER;

AGED; AGED, 80 AND OVER; BRAIN MAPPING; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MILD COGNITIVE IMPAIRMENT; NEUROPSYCHOLOGICAL TESTS; PARKINSON DISEASE; SEVERITY OF ILLNESS INDEX; WHITE MATTER;

EID: 84898013138     PISSN: 10659471     EISSN: 10970193     Source Type: Journal    
DOI: 10.1002/hbm.22302     Document Type: Article

References (59)

1. Agosta F, Canu E, Stojkovic T, Pievani M, Tomic A, Sarro L, Dragasevic N, Copetti M, Comi G, Kostic VS, Filippi M (2012): The topography of brain damage at different stages of Parkinson's disease. Hum Brain Mapp.
2. Apostolova LG, Beyer M, Green AE, Hwang KS, Morra JH, Chou YY, Avedissian C, Aarsland D, Janvin CC, Larsen JP, Cummings JL, Thompson PM (2010): Hippocampal, caudate, and ventricular changes in Parkinson's disease with and without dementia. Mov Disord 25:687-695.
3. Ashburner J (2007): A fast diffeomorphic image registration algorithm. Neuroimage 38:95-113.
4. Ashburner J, Friston KJ (2005): Unified segmentation. Neuroimage 26:839-851.
5. Association AP (1994): Diagnostic and Statistical Manual of Mental Disorders. Association AP.
6. Basser PJ, Mattiello J, Lebihan D (1994): Estimation of the effective self-diffusion tensor from the NMR spin echo. J Magn Reson B 103:247-254.
7. Bertrand JA, Bedetti C, Postuma RB, Monchi O, Genier Marchand D, Jubault T, Gagnon JF (2010): Color discrimination deficits in Parkinson's disease are related to cognitive impairment and white-matter alterations. Mov Disord 27:1781-1788.
8. Beyer MK, Aarsland D, Greve OJ, Larsen JP (2006): Visual rating of white matter hyperintensities in Parkinson's disease. Mov Disord 21:223-229.
9. Beyer MK, Janvin CC, Larsen JP, Aarsland D (2007): A magnetic resonance imaging study of patients with Parkinson's disease with mild cognitive impairment and dementia using voxel-based morphometry. J Neurol Neurosurg Psychiatry 78:254-259.
10. Bohnen NI, Albin RL (2011): White matter lesions in Parkinson disease. Nat Rev Neurol 7:229-236.
11. Bozzali M, Falini A, Cercignani M, Baglio F, Farina E, Alberoni M, Vezzulli P, Olivotto F, Mantovani F, Shallice T, Scotti G, Canal N, Nemni R (2005): Brain tissue damage in dementia with Lewy bodies: An in vivo diffusion tensor MRI study. Brain 128:1595-1604.
12. Braak H, Sandmann-Keil D, Gai W, Braak E (1999): Extensive axonal Lewy neurites in Parkinson's disease: A novel pathological feature revealed by alpha-synuclein immunocytochemistry. Neurosci Lett 265:67-69.
13. Burton EJ, Mckeith IG, Burn DJ, Williams ED, O'brien JT (2004): Cerebral atrophy in Parkinson's disease with and without dementia: A comparison with Alzheimer's disease, dementia with Lewy bodies and controls. Brain 127:791-800.
14. Burton EJ, Mckeith IG, Burn DJ, O'brien JT (2005): Brain atrophy rates in Parkinson's disease with and without dementia using serial magnetic resonance imaging. Mov Disord 20:1571-1576.
15. Caviness JN, Driver-Dunckley E, Connor DJ, Sabbagh MN, Hentz JG, Noble B, Evidente VG, Shill HA, Adler CH (2007): Defining mild cognitive impairment in Parkinson's disease. Mov Disord 22:1272-1277.
16. Choi SA, Evidente VG, Caviness JN, Shill HA, Sabbagh MN, Connor DJ, Hentz JG, Adler CH, Beach TG (2010): Are there differences in cerebral white matter lesion burdens between Parkinson's disease patients with or without dementia? Acta Neuropathol 119:147-149.
17. Collette F, Olivier L, Van der Linden M, Laureys S, Delfiore G, Luxen A, Salmon E (2005): Involvement of both prefrontal and inferior parietal cortex in dual-task performance. Brain Res Cogn Brain Res 24:237-251.
18. Dalaker TO, Zivadinov R, Larsen JP, Beyer MK, Cox JL, Alves G, Bronnick K, Tysnes OB, Antulov R, Dwyer MG, Aarsland D (2010): Gray matter correlations of cognition in incident Parkinson's disease. Mov Disord 25:629-633.
19. Deng B, Zhang Y, Wang L, Peng K, Han L, Nie K, Yang H, Zhang L, Wang J (2013): Diffusion tensor imaging reveals white matter changes associated with cognitive status in patients with Parkinson's disease. Am J Alzheimers Dis Other Demen 28:154-164.
20. Dubois B, Slachevsky A, Litvan I, Pillon B (2000): The FAB: A Frontal Assessment Battery at bedside. Neurology 55:1621-1626.
21. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S, Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, Mckeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, Emre M (2007): Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force. Mov Disord 22:2314-2324.
22. Emre M (2003): Dementia associated with Parkinson's disease. Lancet Neurol 2:229-237.
23. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-62.
24. Hattori T, Orimo S, Aoki S, Ito K, Abe O, Amano A, Sato R, Sakai K, Mizusawa H (2012): Cognitive status correlates with white matter alteration in Parkinson's disease. Hum Brain Mapp 33:727-739.
25. Hely MA, Reid WG, Adena MA, Halliday GM, Morris JG (2008): The Sydney multicenter study of Parkinson's disease: The inevitability of dementia at 20 years. Mov Disord 23:837-844.
26. Huang C, Mattis P, Perrine K, Brown N, Dhawan V, Eidelberg D (2008): Metabolic abnormalities associated with mild cognitive impairment in Parkinson disease. Neurology 70:1470-1477.
27. Karagulle Kendi AT, Lehericy S, Luciana M, Ugurbil K, Tuite P (2008): Altered diffusion in the frontal lobe in Parkinson disease. AJNR Am J Neuroradiol 29:501-505.
28. Katsuse O, Iseki E, Marui W, Kosaka K (2003): Developmental stages of cortical Lewy bodies and their relation to axonal transport blockage in brains of patients with dementia with Lewy bodies. J Neurol Sci 211:29-35.
29. Kehagia AA, Barker RA, Robbins TW (2010): Neuropsychological and clinical heterogeneity of cognitive impairment and dementia in patients with Parkinson's disease. Lancet Neurol 9:1200-1213.
30. Lee JE, Park B, Song SK, Sohn YH, Park HJ, Lee PH (2010a): A comparison of gray and white matter density in patients with Parkinson's disease dementia and dementia with Lewy bodies using voxel-based morphometry. Mov Disord 25:28-34.
31. Lee JE, Park HJ, Park B, Song SK, Sohn YH, Lee JD, Lee PH (2010b): A comparative analysis of cognitive profiles and white-matter alterations using voxel-based diffusion tensor imaging between patients with Parkinson's disease dementia and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry 81:320-326.
32. Lee JE, Park HJ, Song SK, Sohn YH, Lee JD, Lee PH (2010c): Neuroanatomic basis of amnestic MCI differs in patients with and without Parkinson disease. Neurology 75:2009-2016.
33. Lee SJ, Kim JS, Yoo JY, Song IU, Kim BS, Jung SL, Yang DW, Kim YI, Jeong DS, Lee KS (2010d): Influence of white matter hyperintensities on the cognition of patients with Parkinson disease. Alzheimer Dis Assoc Disord 24:227-233.
34. Litvan I, Goldman JG, Troster AI, Schmand BA, Weintraub D, Petersen RC, Mollenhauer B, Adler CH, Marder K, Williams-Gray CH, Aarsland D, Kulisevsky J, Rodriguez-Oroz MC, Burn DJ, Barker RA, Emre M (2012): Diagnostic criteria for mild cognitive impairment in Parkinson's disease: Movement Disorder Society Task Force guidelines. Mov Disord 27:349-356.
35. Matsui H, Nishinaka K, Oda M, Niikawa H, Komatsu K, Kubori T, Udaka F (2007): Wisconsin Card Sorting Test in Parkinson's disease: Diffusion tensor imaging. Acta Neurol Scand 116:108-112.
36. Mclaren DG, Kosmatka KJ, Kastman EK, Bendlin BB, Johnson SC (2009): Rhesus macaque brain morphometry: A methodological comparison of voxel-wise approaches. Methods 50:157-165.
37. Melzer TR, Watts R, Macaskill MR, Pitcher TL, Livingston L, Keenan RJ, Dalrymple-Alford JC, Anderson TJ (2012): Grey matter atrophy in cognitively impaired Parkinson's disease. J Neurol Neurosurg Psychiatry 83:188-194.
38. Mioshi E, Dawson K, Mitchell J, Arnold R, Hodges JR (2006): The Addenbrooke's Cognitive Examination Revised (ACE-R): A brief cognitive test battery for dementia screening. Int J Geriatr Psychiatry 21:1078-1085.
39. Nagano-Saito A, Washimi Y, Arahata Y, Kachi T, Lerch JP, Evans AC, Dagher A, Ito K (2005): Cerebral atrophy and its relation to cognitive impairment in Parkinson disease. Neurology 64:224-229.
40. Nichols TE, Holmes AP (2002): Nonparametric permutation tests for functional neuroimaging: A primer with examples. Hum Brain Mapp 15:1-25.
41. Peppard RF, Martin WR, Carr GD, Grochowski E, Schulzer M, Guttman M, Mcgeer PL, Phillips AG, Tsui JK, Calne DB (1992): Cerebral glucose metabolism in Parkinson's disease with and without dementia. Arch Neurol 49:1262-1268.
42. Pereira JB, Ibarretxe-Bilbao N, Marti MJ, Compta Y, Junque C, Bargallo N, Tolosa E (2011): Assessment of cortical degeneration in patients with Parkinson's disease by voxel-based morphometry, cortical folding, and cortical thickness. Hum Brain Mapp 33:2521-2534.
43. Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999): Mild cognitive impairment: Clinical characterization and outcome. Arch Neurol 56:303-308.
44. Pierpaoli C, Jezzard P, Basser PJ, Barnett A, Di Chiro G (1996): Diffusion tensor MR imaging of the human brain. Radiology 201:637-648.
45. Rae CL, Correia MM, Altena E, Hughes LE, Barker RA, Rowe JB (2012): White matter pathology in Parkinson's disease: The effect of imaging protocol differences and relevance to executive function. Neuroimage 62:1675-1684.
46. Ramirez-Ruiz B, Marti MJ, Tolosa E, Bartres-Faz D, Summerfield C, Salgado-Pineda P, Gomez-Anson B, Junque C (2005): Longitudinal evaluation of cerebral morphological changes in Parkinson's disease with and without dementia. J Neurol 252:1345-1352.
47. Rey A (1964): L'examen Clinique en Psychologie. Paris: Presses Universitaires.
48. Smith SM, Nichols TE (2009): Threshold-free cluster enhancement: Addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 44:83-98.
49. Smith SM, Jenkinson M, Johansen-Berg H, Rueckert D, Nichols TE, Mackay CE, Watkins KE, Ciccarelli O, Cader MZ, Matthews PM, Behrens TE (2006): Tract-based spatial statistics: Voxelwise analysis of multi-subject diffusion data. Neuroimage 31:1487-1505.
50. Sohn MH, Ursu S, Anderson JR, Stenger VA, Carter CS (2000): The role of prefrontal cortex and posterior parietal cortex in task switching. Proc Natl Acad Sci USA 97:13448-13453.
51. Sollinger AB, Goldstein FC, Lah JJ, Levey AI, Factor SA (2010): Mild cognitive impairment in Parkinson's disease: Subtypes and motor characteristics. Parkinsonism Relat Disord 16:177-180.
52. Song SK, Lee JE, Park HJ, Sohn YH, Lee JD, Lee PH (2011): The pattern of cortical atrophy in patients with Parkinson's disease according to cognitive status. Mov Disord 26:289-296.
53. Studholme C, Hill DL, Hawkes DJ (1997): Automated three-dimensional registration of magnetic resonance and positron emission tomography brain images by multiresolution optimization of voxel similarity measures. Med Phys 24:25-35.
54. Summerfield C, Junque C, Tolosa E, Salgado-Pineda P, Gomez-Anson B, Marti MJ, Pastor P, Ramirez-Ruiz B, Mercader J (2005): Structural brain changes in Parkinson disease with dementia: A voxel-based morphometry study. Arch Neurol 62:281-285.
55. Tam CW, Burton EJ, Mckeith IG, Burn DJ, O'brien JT (2005): Temporal lobe atrophy on MRI in Parkinson disease with dementia: A comparison with Alzheimer disease and dementia with Lewy bodies. Neurology 64:861-865.
56. Whitwell JL, Josephs KA (2007): Voxel-based morphometry and its application to movement disorders. Parkinsonism Relat Disord 13:S406-S416.
57. Williams-Gray CH, Foltynie T, Brayne CE, Robbins TW, Barker RA (2007): Evolution of cognitive dysfunction in an incident Parkinson's disease cohort. Brain 130:1787-1798.
58. Williams-Gray CH, Hampshire A, Barker RA, Owen AM (2008): Attentional control in Parkinson's disease is dependent on COMT val 158 met genotype. Brain 131:397-408.
59. Zakzanis KK, Mraz R, Graham SJ (2005): An fMRI study of the Trail Making Test. Neuropsychologia 43:1878-1886.